首页 > 最新文献

Pain Research and Treatment最新文献

英文 中文
Clinical Features of Idiopathic Parotid Pain Triggered by the First Bite in Japanese Patients with Type 2 Diabetes: A Case Study of Nine Patients. 日本2型糖尿病患者首次咬伤引发的特发性腮腺疼痛的临床特征:9例病例研究
Q2 Medicine Pub Date : 2018-03-29 eCollection Date: 2018-01-01 DOI: 10.1155/2018/7861451
Masatoshi Chiba, Hiroaki Hirotani, Tetsu Takahashi

Objective: First bite syndrome, characterized by pain in the parotid region after the first bite of each meal, predominantly develops in patients who have had head and neck surgery. Idiopathic parotid pain (IPP) that mimics first bite syndrome may present in patients without a history of surgery or evidence of an underlying tumor, but its clinical features are unclear. This study characterized the clinical characteristics of IPP in patients with diabetes.

Study design: A retrospective case review involving the clinical findings and pain characteristics of nine patients with IPP and diabetes who presented to our department between 2013 and 2016.

Results: All the patients were men diagnosed with type 2 diabetes (median age, 43 years). IPP developed unilaterally in seven patients and bilaterally in two. The median intensity of the first bite pain was 8 on a numerical rating scale of 0-10. The trigger factor was gustatory stimuli, and the trigger area was the posterior section of the tongue. Postprandial pain occurred within 1-10 min after meals in six patients.

Conclusions: IPP may be considered a separate disorder, in which the pain characteristics are similar to those of first bite syndrome but the clinical features and pathophysiology are different.

目的:首次咬合综合征主要发生在头颈部手术患者中,其特征是每次用餐第一口后腮腺区疼痛。模仿第一咬综合征的特发性腮腺疼痛(IPP)可能出现在没有手术史或潜在肿瘤证据的患者中,但其临床特征尚不清楚。本研究探讨糖尿病患者IPP的临床特点。研究设计:回顾性分析2013 - 2016年在我科就诊的9例IPP合并糖尿病患者的临床表现和疼痛特征。结果:所有患者均为诊断为2型糖尿病的男性(中位年龄43岁)。7例患者单侧发生IPP, 2例患者双侧发生IPP。首次咬痛的中位强度在0-10的数值评定量表上为8。触发因子为味觉刺激,触发区域为舌后段。6例患者餐后疼痛发生在餐后1 ~ 10分钟内。结论:IPP可视为一种单独的疾病,其疼痛特征与第一咬综合征相似,但临床特征和病理生理不同。
{"title":"Clinical Features of Idiopathic Parotid Pain Triggered by the First Bite in Japanese Patients with Type 2 Diabetes: A Case Study of Nine Patients.","authors":"Masatoshi Chiba,&nbsp;Hiroaki Hirotani,&nbsp;Tetsu Takahashi","doi":"10.1155/2018/7861451","DOIUrl":"https://doi.org/10.1155/2018/7861451","url":null,"abstract":"<p><strong>Objective: </strong>First bite syndrome, characterized by pain in the parotid region after the first bite of each meal, predominantly develops in patients who have had head and neck surgery. Idiopathic parotid pain (IPP) that mimics first bite syndrome may present in patients without a history of surgery or evidence of an underlying tumor, but its clinical features are unclear. This study characterized the clinical characteristics of IPP in patients with diabetes.</p><p><strong>Study design: </strong>A retrospective case review involving the clinical findings and pain characteristics of nine patients with IPP and diabetes who presented to our department between 2013 and 2016.</p><p><strong>Results: </strong>All the patients were men diagnosed with type 2 diabetes (median age, 43 years). IPP developed unilaterally in seven patients and bilaterally in two. The median intensity of the first bite pain was 8 on a numerical rating scale of 0-10. The trigger factor was gustatory stimuli, and the trigger area was the posterior section of the tongue. Postprandial pain occurred within 1-10 min after meals in six patients.</p><p><strong>Conclusions: </strong>IPP may be considered a separate disorder, in which the pain characteristics are similar to those of first bite syndrome but the clinical features and pathophysiology are different.</p>","PeriodicalId":19786,"journal":{"name":"Pain Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-03-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/7861451","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36127278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Effects of a Single Dose of Parecoxib on Inflammatory Response and Ischemic Tubular Injury Caused by Hemorrhagic Shock in Rats. 单剂量帕瑞昔布对失血性休克大鼠炎症反应及缺血性小管损伤的影响。
Q2 Medicine Pub Date : 2018-02-04 eCollection Date: 2018-01-01 DOI: 10.1155/2018/8375746
Mariana Takaku, Andre Carnevali da Silva, Nathalie Izumi Iritsu, Pedro Thadeu Galvao Vianna, Yara Marcondes Machado Castiglia

Parecoxib, a selective COX-2 inhibitor, is used to improve analgesia in postoperative procedures. Here we evaluated whether pretreatment with a single dose of parecoxib affects the function, cell injury, and inflammatory response of the kidney of rats subjected to acute hemorrhage. Inflammatory response was determined according to serum and renal tissue cytokine levels (IL-1α, IL-1β, IL-6, IL-10, and TNF-α). Forty-four adult Wistar rats anesthetized with sevoflurane were randomized into four groups: placebo/no hemorrhage (Plc/NH); parecoxib/no hemorrhage (Pcx/NH); placebo/hemorrhage (Plc/H); and parecoxib/hemorrhage (Pcx/H). Pcx groups received a single dose of intravenous parecoxib while Plc groups received a single dose of placebo (isotonic saline). Animals in hemorrhage groups underwent bleeding of 30% of blood volume. Renal function and renal histology were then evaluated. Plc/H showed the highest serum levels of cytokines, suggesting that pretreatment with parecoxib reduced the inflammatory response in rats subjected to hemorrhage. No difference in tissue cytokine levels between groups was observed. Plc/H showed higher percentage of tubular dilation and degeneration, indicating that parecoxib inhibited tubular injury resulting from renal hypoperfusion. Our findings indicate that pretreatment with a single dose of parecoxib reduced the inflammatory response and tubular renal injury without altering renal function in rats undergoing acute hemorrhage.

帕瑞昔布是一种选择性COX-2抑制剂,用于改善术后手术的镇痛。在这里,我们评估了单剂量帕瑞昔布预处理是否会影响急性出血大鼠的肾脏功能、细胞损伤和炎症反应。根据血清和肾组织细胞因子(IL-1α、IL-1β、IL-6、IL-10和TNF-α)水平测定炎症反应。将44只七氟醚麻醉的成年Wistar大鼠随机分为四组:安慰剂组/无出血组(Plc/NH);帕瑞昔布/无出血(Pcx/NH);安慰剂/出血(Plc) / H);帕瑞昔布/出血(Pcx/H)。Pcx组给予单剂量静脉注射帕瑞昔布,Plc组给予单剂量安慰剂(等渗盐水)。出血组的动物出血量为血容量的30%。然后评估肾功能和肾脏组织学。Plc/H显示出最高的血清细胞因子水平,表明帕瑞昔布预处理可以降低出血大鼠的炎症反应。各组间组织细胞因子水平无差异。Plc/H显示肾小管扩张和退变的比例较高,表明帕瑞昔布抑制肾灌注不足引起的肾小管损伤。我们的研究结果表明,单剂量帕瑞昔布预处理可以减轻急性出血大鼠的炎症反应和肾小管损伤,而不会改变肾功能。
{"title":"Effects of a Single Dose of Parecoxib on Inflammatory Response and Ischemic Tubular Injury Caused by Hemorrhagic Shock in Rats.","authors":"Mariana Takaku,&nbsp;Andre Carnevali da Silva,&nbsp;Nathalie Izumi Iritsu,&nbsp;Pedro Thadeu Galvao Vianna,&nbsp;Yara Marcondes Machado Castiglia","doi":"10.1155/2018/8375746","DOIUrl":"https://doi.org/10.1155/2018/8375746","url":null,"abstract":"<p><p>Parecoxib, a selective COX-2 inhibitor, is used to improve analgesia in postoperative procedures. Here we evaluated whether pretreatment with a single dose of parecoxib affects the function, cell injury, and inflammatory response of the kidney of rats subjected to acute hemorrhage. Inflammatory response was determined according to serum and renal tissue cytokine levels (IL-1<i>α</i>, IL-1<i>β</i>, IL-6, IL-10, and TNF-<i>α</i>). Forty-four adult Wistar rats anesthetized with sevoflurane were randomized into four groups: placebo/no hemorrhage (Plc/NH); parecoxib/no hemorrhage (Pcx/NH); placebo/hemorrhage (Plc/H); and parecoxib/hemorrhage (Pcx/H). Pcx groups received a single dose of intravenous parecoxib while Plc groups received a single dose of placebo (isotonic saline). Animals in hemorrhage groups underwent bleeding of 30% of blood volume. Renal function and renal histology were then evaluated. Plc/H showed the highest serum levels of cytokines, suggesting that pretreatment with parecoxib reduced the inflammatory response in rats subjected to hemorrhage. No difference in tissue cytokine levels between groups was observed. Plc/H showed higher percentage of tubular dilation and degeneration, indicating that parecoxib inhibited tubular injury resulting from renal hypoperfusion. Our findings indicate that pretreatment with a single dose of parecoxib reduced the inflammatory response and tubular renal injury without altering renal function in rats undergoing acute hemorrhage.</p>","PeriodicalId":19786,"journal":{"name":"Pain Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/8375746","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35910217","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Evaluating the Measurement Properties of the Self-Assessment of Treatment Version II, Follow-Up Version, in Patients with Painful Diabetic Peripheral Neuropathy 评估疼痛型糖尿病周围神经病变患者自我评估治疗版本II(随访版本)的测量特性
Q2 Medicine Pub Date : 2017-01-16 DOI: 10.1155/2017/6080648
F. V. van Nooten, D. Trundell, D. Staniewska, Jun Chen, E. Davies, D. Revicki
Background. The Self-Assessment of Treatment version II (SAT II) measures treatment-related improvements in pain and impacts and impressions of treatment in neuropathic pain patients. The measure has baseline and follow-up versions. This study assesses the measurement properties of the SAT II. Methods. Data from 369 painful diabetic peripheral neuropathy (PDPN) patients from a phase III trial assessing capsaicin 8% patch (Qutenza®) efficacy and safety were used in these analyses. Reliability, convergent validity, known-groups validity, and responsiveness (using the Brief Pain Inventory-Diabetic Neuropathy [BPI-DN] and Patient Global Impression of Change [PGIC]) analyses were conducted, and minimally important differences (MID) were estimated. Results. Exploratory factor analysis supported a one-factor solution for the six impact items. The SAT II has good internal consistency (Cronbach's alpha: 0.96) and test-retest reliability (intraclass correlation coefficients: 0.62–0.88). Assessment of convergent validity showed moderate to strong correlations with change in other study endpoints. Scores varied significantly by level of pain intensity and sleep interference (p < 0.05) defined by the BPI-DN. Responsiveness was shown based on the PGIC. MID estimates ranged from 1.2 to 2.4 (pain improvement) and 1.0 to 2.0 (impact scores). Conclusions. The SAT II is a reliable and valid measure for assessing treatment improvement in PDPN patients.
背景。治疗自我评估第二版(SAT II)测量治疗相关的疼痛改善和神经性疼痛患者治疗的影响和印象。该措施有基线和后续版本。本研究评估了SAT II的测量特性。方法。来自369名疼痛性糖尿病周围神经病变(PDPN)患者的III期试验数据用于评估辣椒素8%贴剂(Qutenza®)的疗效和安全性。进行了信度、收敛效度、已知组效度和反应性(使用简短疼痛量表-糖尿病神经病变[BPI-DN]和患者总体变化印象[PGIC])分析,并估计了最小重要差异(MID)。结果。探索性因素分析支持六个影响项目的单因素解决方案。SAT II具有良好的内部一致性(Cronbach's alpha: 0.96)和重测信度(类内相关系数:0.62-0.88)。收敛效度评估显示与其他研究终点的变化有中等到强的相关性。由BPI-DN定义的疼痛强度和睡眠干扰水平的评分差异显著(p < 0.05)。反应性以PGIC为基础。MID估计范围从1.2到2.4(疼痛改善)和1.0到2.0(影响评分)。结论。SAT II是评估PDPN患者治疗改善的可靠和有效的措施。
{"title":"Evaluating the Measurement Properties of the Self-Assessment of Treatment Version II, Follow-Up Version, in Patients with Painful Diabetic Peripheral Neuropathy","authors":"F. V. van Nooten, D. Trundell, D. Staniewska, Jun Chen, E. Davies, D. Revicki","doi":"10.1155/2017/6080648","DOIUrl":"https://doi.org/10.1155/2017/6080648","url":null,"abstract":"Background. The Self-Assessment of Treatment version II (SAT II) measures treatment-related improvements in pain and impacts and impressions of treatment in neuropathic pain patients. The measure has baseline and follow-up versions. This study assesses the measurement properties of the SAT II. Methods. Data from 369 painful diabetic peripheral neuropathy (PDPN) patients from a phase III trial assessing capsaicin 8% patch (Qutenza®) efficacy and safety were used in these analyses. Reliability, convergent validity, known-groups validity, and responsiveness (using the Brief Pain Inventory-Diabetic Neuropathy [BPI-DN] and Patient Global Impression of Change [PGIC]) analyses were conducted, and minimally important differences (MID) were estimated. Results. Exploratory factor analysis supported a one-factor solution for the six impact items. The SAT II has good internal consistency (Cronbach's alpha: 0.96) and test-retest reliability (intraclass correlation coefficients: 0.62–0.88). Assessment of convergent validity showed moderate to strong correlations with change in other study endpoints. Scores varied significantly by level of pain intensity and sleep interference (p < 0.05) defined by the BPI-DN. Responsiveness was shown based on the PGIC. MID estimates ranged from 1.2 to 2.4 (pain improvement) and 1.0 to 2.0 (impact scores). Conclusions. The SAT II is a reliable and valid measure for assessing treatment improvement in PDPN patients.","PeriodicalId":19786,"journal":{"name":"Pain Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2017/6080648","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48026224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome. 棕榈酰乙醇酰胺治疗背部手术失败综合征。
Q2 Medicine Pub Date : 2017-01-01 Epub Date: 2017-08-10 DOI: 10.1155/2017/1486010
Antonella Paladini, Giustino Varrassi, Giuseppe Bentivegna, Sandro Carletti, Alba Piroli, Stefano Coaccioli
Introduction This observational study was designed to evaluate the efficacy of ultramicronized palmitoylethanolamide (um-PEA) (Normast®) administration, as add-on therapy for chronic pain, in the management of pain-resistant patients affected by failed back surgery syndrome. Methods A total of 35 patients were treated with tapentadol (TPD) and pregabalin (PGB). One month after the start of standard treatment, um-PEA was added for the next two months. Pain was evaluated by the Visual Analogue Scale (VAS) at the time of enrollment (T0) and after one (T1), two (T2), and three (T3) months. Results After the first month with TDP + PGB treatment only, VAS score decreased significantly from 5.7 ± 0.12 at the time of enrollment (T0) to 4.3 ± 0.11 (T1) (p < 0.0001); however, it failed to provide significant subjective improvement in pain symptoms. Addition of um-PEA led to a further and significant decrease in pain intensity, reaching VAS scores of 2.7 ± 0.09 (T2) and 1.7 ± 0.11 (T3, end of treatment) (p < 0.0001) without showing any side effects. Conclusions This observational study provides evidence, albeit preliminary, for the efficacy and safety of um-PEA (Normast) as part of a multimodal therapeutic regimen in the treatment of pain-resistant patients suffering from failed back surgery syndrome.
本观察性研究旨在评估超微化棕榈酰乙醇酰胺(um-PEA) (Normast®)作为慢性疼痛的附加治疗,在治疗背部手术失败综合征的疼痛耐受性患者中的疗效。方法:35例患者采用他他多(TPD)联合普瑞巴林(PGB)治疗。标准治疗开始一个月后,在接下来的两个月里添加um-PEA。在入组时(T0)和1个月(T1)、2个月(T2)和3个月(T3)后,采用视觉模拟评分(VAS)评估疼痛。结果:仅TDP + PGB治疗1个月后,VAS评分由入组时的5.7±0.12 (T0)降至4.3±0.11 (T1) (p < 0.0001);然而,它不能提供明显的主观改善疼痛症状。添加um-PEA可进一步显著降低疼痛强度,VAS评分分别为2.7±0.09 (T2)和1.7±0.11 (T3,治疗结束)(p < 0.0001),无任何副作用。结论:这项观察性研究为um-PEA (Normast)作为多模式治疗方案的一部分用于治疗背部手术失败综合征的疼痛耐受性患者的有效性和安全性提供了初步证据。
{"title":"Palmitoylethanolamide in the Treatment of Failed Back Surgery Syndrome.","authors":"Antonella Paladini,&nbsp;Giustino Varrassi,&nbsp;Giuseppe Bentivegna,&nbsp;Sandro Carletti,&nbsp;Alba Piroli,&nbsp;Stefano Coaccioli","doi":"10.1155/2017/1486010","DOIUrl":"https://doi.org/10.1155/2017/1486010","url":null,"abstract":"Introduction This observational study was designed to evaluate the efficacy of ultramicronized palmitoylethanolamide (um-PEA) (Normast®) administration, as add-on therapy for chronic pain, in the management of pain-resistant patients affected by failed back surgery syndrome. Methods A total of 35 patients were treated with tapentadol (TPD) and pregabalin (PGB). One month after the start of standard treatment, um-PEA was added for the next two months. Pain was evaluated by the Visual Analogue Scale (VAS) at the time of enrollment (T0) and after one (T1), two (T2), and three (T3) months. Results After the first month with TDP + PGB treatment only, VAS score decreased significantly from 5.7 ± 0.12 at the time of enrollment (T0) to 4.3 ± 0.11 (T1) (p < 0.0001); however, it failed to provide significant subjective improvement in pain symptoms. Addition of um-PEA led to a further and significant decrease in pain intensity, reaching VAS scores of 2.7 ± 0.09 (T2) and 1.7 ± 0.11 (T3, end of treatment) (p < 0.0001) without showing any side effects. Conclusions This observational study provides evidence, albeit preliminary, for the efficacy and safety of um-PEA (Normast) as part of a multimodal therapeutic regimen in the treatment of pain-resistant patients suffering from failed back surgery syndrome.","PeriodicalId":19786,"journal":{"name":"Pain Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2017/1486010","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35475752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Kinesiophobia, Pain, Muscle Functions, and Functional Performances among Older Persons with Low Back Pain. 老年腰痛患者的运动恐惧症、疼痛、肌肉功能和功能表现。
Q2 Medicine Pub Date : 2017-01-01 Epub Date: 2017-05-29 DOI: 10.1155/2017/3489617
Nor Azizah Ishak, Zarina Zahari, Maria Justine

Objectives: This study aims (1) to determine the association between kinesiophobia and pain, muscle functions, and functional performances and (2) to determine whether kinesiophobia predicts pain, muscle functions, and functional performance among older persons with low back pain (LBP).

Methods: This is a correlational study, involving 63 institutionalized older persons (age = 70.98 ± 7.90 years) diagnosed with LBP. Anthropometric characteristics (BMI) and functional performances (lower limb function, balance and mobility, and hand grip strength) were measured. Muscle strength (abdominal and back muscle strength) was assessed using the Baseline® Mechanical Push/Pull Dynamometer, while muscle control (transverse abdominus and multifidus) was measured by using the Pressure Biofeedback Unit. The pain intensity and the level of kinesiophobia were measured using Numerical Rating Scale and Tampa Scale of Kinesiophobia, respectively. Data were analyzed using Pearson's correlation coefficients and multivariate linear regressions.

Results: No significant correlations were found between kinesiophobia and pain and muscle functions (all p > 0.05). Kinesiophobia was significantly correlated with mobility and balance (p = 0.038, r = 0.263). Regressions analysis showed that kinesiophobia was a significant predictor of mobility and balance (p = 0.038).

Conclusion: We can conclude that kinesiophobia predicted mobility and balance in older persons with LBP. Kinesiophobia should be continuously assessed in clinical settings to recognize the obstacles that may affect patient's compliance towards a rehabilitation program in older persons with LBP.

目的:本研究旨在(1)确定运动恐惧症与疼痛、肌肉功能和功能表现之间的关系;(2)确定运动恐惧症是否能预测老年腰痛(LBP)患者的疼痛、肌肉功能和功能表现。方法:本研究是一项相关研究,纳入63例确诊为腰痛的住院老年人(年龄= 70.98±7.90岁)。测量人体测量特征(BMI)和功能表现(下肢功能、平衡和活动能力以及手部握力)。肌肉力量(腹部和背部肌肉力量)使用Baseline®机械推/拉测功仪进行评估,而肌肉控制(横腹和多裂肌)使用压力生物反馈装置进行测量。疼痛强度和运动恐惧症水平分别采用数值评定量表和坦帕运动恐惧症量表进行测量。数据分析采用Pearson相关系数和多元线性回归。结果:运动恐惧症与疼痛、肌肉功能无显著相关性(p > 0.05)。运动恐惧症与活动能力和平衡能力显著相关(p = 0.038, r = 0.263)。回归分析显示,运动恐惧症是活动能力和平衡能力的显著预测因子(p = 0.038)。结论:运动恐惧症预示着老年腰痛患者的活动能力和平衡能力。应在临床环境中持续评估运动恐惧症,以识别可能影响老年腰痛患者对康复计划的依从性的障碍。
{"title":"Kinesiophobia, Pain, Muscle Functions, and Functional Performances among Older Persons with Low Back Pain.","authors":"Nor Azizah Ishak,&nbsp;Zarina Zahari,&nbsp;Maria Justine","doi":"10.1155/2017/3489617","DOIUrl":"https://doi.org/10.1155/2017/3489617","url":null,"abstract":"<p><strong>Objectives: </strong>This study aims (1) to determine the association between kinesiophobia and pain, muscle functions, and functional performances and (2) to determine whether kinesiophobia predicts pain, muscle functions, and functional performance among older persons with low back pain (LBP).</p><p><strong>Methods: </strong>This is a correlational study, involving 63 institutionalized older persons (age = 70.98 ± 7.90 years) diagnosed with LBP. Anthropometric characteristics (BMI) and functional performances (lower limb function, balance and mobility, and hand grip strength) were measured. Muscle strength (abdominal and back muscle strength) was assessed using the Baseline® Mechanical Push/Pull Dynamometer, while muscle control (transverse abdominus and multifidus) was measured by using the Pressure Biofeedback Unit. The pain intensity and the level of kinesiophobia were measured using Numerical Rating Scale and Tampa Scale of Kinesiophobia, respectively. Data were analyzed using Pearson's correlation coefficients and multivariate linear regressions.</p><p><strong>Results: </strong>No significant correlations were found between kinesiophobia and pain and muscle functions (all <i>p</i> > 0.05). Kinesiophobia was significantly correlated with mobility and balance (<i>p</i> = 0.038, <i>r</i> = 0.263). Regressions analysis showed that kinesiophobia was a significant predictor of mobility and balance (<i>p</i> = 0.038).</p><p><strong>Conclusion: </strong>We can conclude that kinesiophobia predicted mobility and balance in older persons with LBP. Kinesiophobia should be continuously assessed in clinical settings to recognize the obstacles that may affect patient's compliance towards a rehabilitation program in older persons with LBP.</p>","PeriodicalId":19786,"journal":{"name":"Pain Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2017/3489617","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35105955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 45
iACT-CEL: A Feasibility Trial of a Face-to-Face and Internet-Based Acceptance and Commitment Therapy Intervention for Chronic Pain in Singapore. iACT-CEL:新加坡慢性疼痛面对面和基于互联网的接受和承诺治疗干预的可行性试验。
Q2 Medicine Pub Date : 2017-01-01 Epub Date: 2017-02-23 DOI: 10.1155/2017/6916915
Su-Yin Yang, Rona Moss-Morris, Lance M McCracken

Psychological interventions are increasingly utilising online or mobile phone based platforms to deliver treatment, including that for people with chronic pain. The aims of this study were to develop an adapted form of Acceptance and Commitment Therapy (ACT) for chronic pain in Singapore and to test the feasibility of elements of this treatment delivered via the internet and email. Methods. Thirty-three participants recruited from a tertiary pain management clinic and via the clinic website participated in this program over a period of five weeks with a 3-month follow-up. Treatment outcomes were assessed at three assessment time points. Results. 90.9% of participants completed the program, with 81.8% reporting high treatment satisfaction. Significant changes in depression, t = 3.08, p = 0.002 (baseline to posttreatment), t = 3.28, p = 0.001 (baseline to follow-up), and pain intensity, t = 2.15, p = 0.03 (baseline to follow-up) were found. Mainly small effect sizes (d = 0.09-0.39) with a moderate effect size (d = 0.51) for depression were found at posttreatment. Clinically meaningful improvement in at least one outcome was demonstrated in 75.8% of participants. Conclusions. An adaptation of ACT for people with chronic pain in Singapore appears promising. Optimal treatment design and more effective ways to target outcomes and processes measured here are required.

心理干预越来越多地利用在线或基于手机的平台来提供治疗,包括对慢性疼痛患者的治疗。本研究的目的是为新加坡的慢性疼痛开发一种适应形式的接受和承诺疗法(ACT),并测试通过互联网和电子邮件提供这种治疗的可行性。方法。从三级疼痛管理诊所招募的33名参与者通过诊所网站参加了这个为期五周的项目,并进行了为期三个月的随访。在三个评估时间点评估治疗结果。结果:90.9%的参与者完成了该计划,81.8%的参与者报告了高的治疗满意度。患者的抑郁程度(t = 3.08, p = 0.002(基线至治疗后),t = 3.28, p = 0.001(基线至随访),疼痛程度(t = 2.15, p = 0.03(基线至随访))均有显著变化。治疗后抑郁症的效应量主要为小效应量(d = 0.09 ~ 0.39)和中等效应量(d = 0.51)。在75.8%的参与者中,至少有一个结果有临床意义的改善。结论。在新加坡,针对慢性疼痛患者的ACT适应似乎很有希望。需要优化治疗设计和更有效的方法来针对这里测量的结果和过程。
{"title":"iACT-CEL: A Feasibility Trial of a Face-to-Face and Internet-Based Acceptance and Commitment Therapy Intervention for Chronic Pain in Singapore.","authors":"Su-Yin Yang,&nbsp;Rona Moss-Morris,&nbsp;Lance M McCracken","doi":"10.1155/2017/6916915","DOIUrl":"https://doi.org/10.1155/2017/6916915","url":null,"abstract":"<p><p>Psychological interventions are increasingly utilising online or mobile phone based platforms to deliver treatment, including that for people with chronic pain. The aims of this study were to develop an adapted form of Acceptance and Commitment Therapy (ACT) for chronic pain in Singapore and to test the feasibility of elements of this treatment delivered via the internet and email. <i>Methods</i>. Thirty-three participants recruited from a tertiary pain management clinic and via the clinic website participated in this program over a period of five weeks with a 3-month follow-up. Treatment outcomes were assessed at three assessment time points. <i>Results</i>. 90.9% of participants completed the program, with 81.8% reporting high treatment satisfaction. Significant changes in depression, <i>t</i> = 3.08, <i>p</i> = 0.002 (baseline to posttreatment), <i>t</i> = 3.28, <i>p</i> = 0.001 (baseline to follow-up), and pain intensity, <i>t</i> = 2.15, <i>p</i> = 0.03 (baseline to follow-up) were found. Mainly small effect sizes (<i>d</i> = 0.09-0.39) with a moderate effect size (<i>d</i> = 0.51) for depression were found at posttreatment. Clinically meaningful improvement in at least one outcome was demonstrated in 75.8% of participants. <i>Conclusions</i>. An adaptation of ACT for people with chronic pain in Singapore appears promising. Optimal treatment design and more effective ways to target outcomes and processes measured here are required.</p>","PeriodicalId":19786,"journal":{"name":"Pain Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2017/6916915","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34841179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials. 纤维肌痛的疼痛加工和植物功能障碍:交感皮肤反应和激光诱发电位的研究。
Q2 Medicine Pub Date : 2017-01-01 Epub Date: 2017-09-28 DOI: 10.1155/2017/9747148
Marina de Tommaso, Katia Ricci, Giuseppe Libro, Eleonora Vecchio, Marianna Delussi, Anna Montemurno, Giuseppe Lopalco, Florenzo Iannone

Background: A dysfunction of pain processing at central and peripheral levels was reported in fibromyalgia (FM). We aimed to correlate laser evoked potentials (LEPs), Sympathetic Skin Response (SSR), and clinical features in FM patients.

Methods: Fifty FM patients and 30 age-matched controls underwent LEPs and SSR by the right hand and foot. The clinical evaluation included FM disability (FIQ) and severity scores (WPI), anxiety (SAS) and depression (SDS) scales, and questionnaires for neuropathic pain (DN4).

Results: The LEP P2 latency and amplitude and the SSR latency were increased in FM group. This latter feature was more evident in anxious patients. The LEPs habituation was reduced in FM patients and correlated to pain severity scores. In a significant number of patients (32%) with higher DN4 and FIQ scores, SSR or LEP responses were absent.

Conclusions: LEPs and SSR might contribute to clarifying the peripheral and central nervous system involvement in FM patients.

背景:据报道,纤维肌痛(FM)中存在中枢和外周水平的疼痛加工功能障碍。我们的目的是将激光诱发电位(LEPs)、交感皮肤反应(SSR)和FM患者的临床特征联系起来。方法:50例FM患者和30例年龄相匹配的对照组分别行右手和足部LEPs和SSR。临床评价包括FM残疾(FIQ)和严重程度评分(WPI),焦虑(SAS)和抑郁(SDS)量表,神经性疼痛(DN4)问卷。结果:FM组LEP P2潜伏期、振幅和SSR潜伏期均增加。后一种特征在焦虑患者中更为明显。FM患者的lep习惯化程度降低,并与疼痛严重程度评分相关。在DN4和FIQ评分较高的大量患者(32%)中,没有SSR或LEP反应。结论:LEPs和SSR可能有助于明确FM患者的外周和中枢神经系统受累情况。
{"title":"Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials.","authors":"Marina de Tommaso, Katia Ricci, Giuseppe Libro, Eleonora Vecchio, Marianna Delussi, Anna Montemurno, Giuseppe Lopalco, Florenzo Iannone","doi":"10.1155/2017/9747148","DOIUrl":"10.1155/2017/9747148","url":null,"abstract":"<p><strong>Background: </strong>A dysfunction of pain processing at central and peripheral levels was reported in fibromyalgia (FM). We aimed to correlate laser evoked potentials (LEPs), Sympathetic Skin Response (SSR), and clinical features in FM patients.</p><p><strong>Methods: </strong>Fifty FM patients and 30 age-matched controls underwent LEPs and SSR by the right hand and foot. The clinical evaluation included FM disability (FIQ) and severity scores (WPI), anxiety (SAS) and depression (SDS) scales, and questionnaires for neuropathic pain (DN4).</p><p><strong>Results: </strong>The LEP P2 latency and amplitude and the SSR latency were increased in FM group. This latter feature was more evident in anxious patients. The LEPs habituation was reduced in FM patients and correlated to pain severity scores. In a significant number of patients (32%) with higher DN4 and FIQ scores, SSR or LEP responses were absent.</p><p><strong>Conclusions: </strong>LEPs and SSR might contribute to clarifying the peripheral and central nervous system involvement in FM patients.</p>","PeriodicalId":19786,"journal":{"name":"Pain Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2017/9747148","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35563463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 29
Interventional Pain Management in Multidisciplinary Chronic Pain Clinics: A Prospective Multicenter Cohort Study with One-Year Follow-Up. 多学科慢性疼痛临床的介入疼痛管理:一项为期一年随访的前瞻性多中心队列研究。
Q2 Medicine Pub Date : 2017-01-01 Epub Date: 2017-10-15 DOI: 10.1155/2017/8402413
Cláudia Gouvinhas, Dalila Veiga, Liliane Mendonça, Rute Sampaio, Luís Filipe Azevedo, José Manuel Castro-Lopes

Background: Interventional Pain Management (IPM) is performed in multidisciplinary chronic pain clinics (MCPC), including a range of invasive techniques to diagnose and treat chronic pain (CP) conditions. Current patterns of use of those techniques in MCPC have not yet been reported.

Objective: We aimed to describe quantitatively and qualitatively the use of IPM and other therapeutic procedures performed on-site at four Portuguese MCPC.

Methods: A prospective cohort study with one-year follow-up was performed in adult patients. A structured case report form was systematically completed at baseline and six and 12 months.

Results: Among 808 patients referred to the MCPC, 17.2% had been prescribed IPM. Patients with IPM were on average younger and had longer CP duration and lower levels of maximum pain and pain interference/disability. The three main diagnoses were low back pain (n = 28), postoperative CP, and knee pain (n = 16 each). From 195 IPM prescribed, nerve blocks (n = 108), radiofrequency (n = 31), and viscosupplementation (n = 22) were the most prevalent. Some IPM techniques were only available in few MCPC. One MCPC did not provide IPM.

Conclusions: IPM are seldom prescribed in Portuguese MCPC. Further studies on IPM safety and effectiveness are necessary for clear understanding the role of these techniques in CP management.

背景:介入性疼痛管理(IPM)在多学科慢性疼痛临床(MCPC)中进行,包括一系列侵入性技术来诊断和治疗慢性疼痛(CP)状况。目前在MCPC中使用这些技术的模式还没有报道。目的:我们旨在定量和定性地描述在四个葡萄牙MCPC现场使用IPM和其他治疗程序。方法:对成年患者进行为期一年的前瞻性队列研究。在基线、第6个月和第12个月系统地完成结构化病例报告表。结果:808例MCPC患者中,17.2%的患者使用了IPM。IPM患者平均年龄较小,CP持续时间较长,最大疼痛和疼痛干扰/残疾水平较低。三个主要诊断为腰痛(n = 28)、术后CP和膝关节疼痛(n = 16)。从处方的195例IPM中,神经阻滞(n = 108)、射频(n = 31)和粘剂补充(n = 22)是最普遍的。一些IPM技术仅适用于少数MCPC。一个MCPC没有提供IPM。结论:葡萄牙MCPC患者很少开IPM。进一步研究IPM的安全性和有效性是明确这些技术在CP管理中的作用的必要条件。
{"title":"Interventional Pain Management in Multidisciplinary Chronic Pain Clinics: A Prospective Multicenter Cohort Study with One-Year Follow-Up.","authors":"Cláudia Gouvinhas,&nbsp;Dalila Veiga,&nbsp;Liliane Mendonça,&nbsp;Rute Sampaio,&nbsp;Luís Filipe Azevedo,&nbsp;José Manuel Castro-Lopes","doi":"10.1155/2017/8402413","DOIUrl":"https://doi.org/10.1155/2017/8402413","url":null,"abstract":"<p><strong>Background: </strong>Interventional Pain Management (IPM) is performed in multidisciplinary chronic pain clinics (MCPC), including a range of invasive techniques to diagnose and treat chronic pain (CP) conditions. Current patterns of use of those techniques in MCPC have not yet been reported.</p><p><strong>Objective: </strong>We aimed to describe quantitatively and qualitatively the use of IPM and other therapeutic procedures performed on-site at four Portuguese MCPC.</p><p><strong>Methods: </strong>A prospective cohort study with one-year follow-up was performed in adult patients. A structured case report form was systematically completed at baseline and six and 12 months.</p><p><strong>Results: </strong>Among 808 patients referred to the MCPC, 17.2% had been prescribed IPM. Patients with IPM were on average younger and had longer CP duration and lower levels of maximum pain and pain interference/disability. The three main diagnoses were low back pain (<i>n</i> = 28), postoperative CP, and knee pain (<i>n</i> = 16 each). From 195 IPM prescribed, nerve blocks (<i>n</i> = 108), radiofrequency (<i>n</i> = 31), and viscosupplementation (<i>n</i> = 22) were the most prevalent. Some IPM techniques were only available in few MCPC. One MCPC did not provide IPM.</p><p><strong>Conclusions: </strong>IPM are seldom prescribed in Portuguese MCPC. Further studies on IPM safety and effectiveness are necessary for clear understanding the role of these techniques in CP management.</p>","PeriodicalId":19786,"journal":{"name":"Pain Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2017/8402413","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35575657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
The Prevalence of and Factors Associated with Neck, Shoulder, and Low-Back Pains among Medical Students at University Hospitals in Central Saudi Arabia. 沙特阿拉伯中部大学医院医学生颈、肩、腰痛的患病率及相关因素
Q2 Medicine Pub Date : 2017-01-01 Epub Date: 2017-11-07 DOI: 10.1155/2017/1235706
Abdulrahman D Algarni, Yazeed Al-Saran, Ahlam Al-Moawi, Abdullah Bin Dous, Abdulaziz Al-Ahaideb, Shaji John Kachanathu

Aim: The study aim was to determine the prevalence of neck, shoulder, and low-back pains and to explore the factors associated with musculoskeletal pain (MSP) among medical students at university hospitals in central Saudi Arabia.

Method: This cross-sectional study was conducted at a government institution using an online self-administered, modified version of the Standardised Nordic Questionnaire in the English language.

Results: A total of 469 students responded to our survey. The prevalence of MSP in at least one body site at any time, in the past week, and in the past year was 85.3%, 54.4%, and 81.9%, respectively. Factors significantly associated with MSP in at least one body site at any time were being in the clinical year (P = 0.032), history of trauma (P  =  0.036), history of depressive symptoms (P < 0.001), and history of psychosomatic symptoms (P < 0.001). On multivariable regression analysis, factors associated with MSP were history of trauma (P = 0.016) and depressive (P = 0.002) or psychosomatic symptoms (P = 0.004).

Conclusion: MSP among Saudi medical students is high, particularly among those in the clinical years and those with history of trauma and with depressive or psychosomatic symptoms. Medical institutions should be aware of this serious health issue and preventive measures are warranted.

目的:本研究旨在确定沙特阿拉伯中部大学医院医学生颈部、肩部和下背部疼痛的患病率,并探讨与肌肉骨骼疼痛(MSP)相关的因素。方法:这项横断面研究是在一个政府机构进行的,使用在线自我管理,修改版的标准化北欧问卷的英语语言。结果:共有469名学生回应了我们的调查。在任何时间、过去一周和过去一年至少有一个身体部位的MSP患病率分别为85.3%、54.4%和81.9%。与任何时间至少一个身体部位的MSP显著相关的因素是处于临床年度(P = 0.032)、创伤史(P = 0.036)、抑郁史(P < 0.001)和心身症状史(P < 0.001)。在多变量回归分析中,与MSP相关的因素是创伤史(P = 0.016)、抑郁史(P = 0.002)或心身症状(P = 0.004)。结论:沙特医科学生的MSP很高,特别是在临床年龄和有创伤史、抑郁或心身症状的学生中。医疗机构应该意识到这一严重的健康问题,并采取必要的预防措施。
{"title":"The Prevalence of and Factors Associated with Neck, Shoulder, and Low-Back Pains among Medical Students at University Hospitals in Central Saudi Arabia.","authors":"Abdulrahman D Algarni,&nbsp;Yazeed Al-Saran,&nbsp;Ahlam Al-Moawi,&nbsp;Abdullah Bin Dous,&nbsp;Abdulaziz Al-Ahaideb,&nbsp;Shaji John Kachanathu","doi":"10.1155/2017/1235706","DOIUrl":"https://doi.org/10.1155/2017/1235706","url":null,"abstract":"<p><strong>Aim: </strong>The study aim was to determine the prevalence of neck, shoulder, and low-back pains and to explore the factors associated with musculoskeletal pain (MSP) among medical students at university hospitals in central Saudi Arabia.</p><p><strong>Method: </strong>This cross-sectional study was conducted at a government institution using an online self-administered, modified version of the Standardised Nordic Questionnaire in the English language.</p><p><strong>Results: </strong>A total of 469 students responded to our survey. The prevalence of MSP in at least one body site at any time, in the past week, and in the past year was 85.3%, 54.4%, and 81.9%, respectively. Factors significantly associated with MSP in at least one body site at any time were being in the clinical year (<i>P</i> = 0.032), history of trauma (<i>P</i>  =  0.036), history of depressive symptoms (<i>P</i> < 0.001), and history of psychosomatic symptoms (<i>P</i> < 0.001). On multivariable regression analysis, factors associated with MSP were history of trauma (<i>P</i> = 0.016) and depressive (<i>P</i> = 0.002) or psychosomatic symptoms (<i>P</i> = 0.004).</p><p><strong>Conclusion: </strong>MSP among Saudi medical students is high, particularly among those in the clinical years and those with history of trauma and with depressive or psychosomatic symptoms. Medical institutions should be aware of this serious health issue and preventive measures are warranted.</p>","PeriodicalId":19786,"journal":{"name":"Pain Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2017/1235706","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35654756","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 59
Corrigendum to "The Role of Descending Modulation in Manual Therapy and Its Analgesic Implications: A Narrative Review". “下行调节在手工治疗中的作用及其镇痛意义:叙述回顾”的勘误表。
Q2 Medicine Pub Date : 2017-01-01 Epub Date: 2017-10-26 DOI: 10.1155/2017/1535473
Andrew D Vigotsky, Ryan P Bruhns

[This corrects the article DOI: 10.1155/2015/292805.].

[这更正了文章DOI: 10.1155/2015/292805.]
{"title":"Corrigendum to \"The Role of Descending Modulation in Manual Therapy and Its Analgesic Implications: A Narrative Review\".","authors":"Andrew D Vigotsky,&nbsp;Ryan P Bruhns","doi":"10.1155/2017/1535473","DOIUrl":"https://doi.org/10.1155/2017/1535473","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1155/2015/292805.].</p>","PeriodicalId":19786,"journal":{"name":"Pain Research and Treatment","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2017/1535473","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35634642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
期刊
Pain Research and Treatment
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1